Mukesh Ambani Tops Forbes List Of Richest Indians Followed By Gautam Adani
The total number of Indian billionaires increased to 140 this year from 102 last year
With a net worth of Rs 8,450 crore, Reliance Industries Chairman Mukesh Ambani regained the first spot in the Forbes list of India's 10 richest people. Mukesh Ambani, who is also Asia's richest person, was followed by Adani Group chief Gautam Adani, who gained the second position, having a net worth of Rs 5,050 crore. Yesterday, the Adani Group became the third Indian company to cross $100 billion in market capitalisation. (Also Read: Adani Group Becomes Third Indian Company To Cross $100 Billion In Market Value )In the Forbes list, the third rank was claimed by HCL Founder Shiv Nadar with a net worth of Rs 2,350 crore. According to Forbes, the total number of Indian billionaires increased to 140 this year from 102 last year.
Meanwhile, according to BSE data, the total market value of six listed Adani Group firms stood at over $104 billion. On Tuesday, shares of four out of six listed Adani Group companies touched all-time highs. The jump in shares came after Adani Ports and Special Economic Zones (APSEZ) acquired a full 100 per cent stake in Krishnapatanma Port of Andhra Pradesh on Monday. (Also Read: Adani Ports Gains After Acquiring 100% Stake In Krishnapatnam Port )Previously, Mukesh Ambani-led-Reliance Industries and Tata Group achieved the milestone of crossing $100 billion in market value. Meanwhile, billionaire Mukesh Ambani plunged into sectors such as retail and telecom and retail. This eventually led him to retain the top position in the richest Indians list. During the COVID-19 pandemic, Reliance Industries' chairman achieved a fund-raising feat. He garnered $35 billion through a series of deals.
The Adani Group acquired a 74 per cent stake in the Mumbai International Airport last year. The Adani Group has acquired stake of several other ports in the financial year 2020-21. Other Indians who featured in the list were Cyrus Poonawalla of the Serum Institute of India (SII) and Dilip Shanghavi of Sun Pharmaceutical Industries.